Holen Sie sich die Stockscreener-App
1.54
0.65%
-0.01
Handel nachbörslich:
1.57
0.03
+1.95%
Finanzdaten der Therapeuticsmd Inc-Aktie (TXMD)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
37.65%
0.313
|
0.502 | -0.053 | 0.437 | 0.416 |
Operating Expenses
|
31.14%
1.455
|
2.113 | 1.72 | 2.909 | 3.083 |
| Benefits Costs and Expenses |
46.21%
1.122
|
2.086 | 1.381 | 2.851 | 2.726 |
| Costs And Expenses |
30.25%
1.455
|
2.086 | 1.381 | 2.851 | 2.726 |
| Operating Income/Loss |
29.11%
-1.142
|
-1.611 | -1.773 | -2.472 | -2.667 |
| Nonoperating Income/Loss |
1,133%
0.333
|
0.027 | 0.339 | 0.058 | 0.357 |
| Income/Loss From Continuing Operations Before Tax |
48.93%
-0.809
|
-1.584 | -1.434 | -2.414 | -2.31 |
| Income/Loss From Continuing Operations After Tax |
47.50%
-0.809
|
-1.541 | -1.434 | -2.414 | -2.31 |
| Income/Loss From Discontinued Operations, Net Of Tax |
88.60%
0.075
|
0.658 | -1.944 | - | -1.293 |
|
Net Income/Loss
|
16.87%
-0.734
|
-0.883 | -3.378 | -2.414 | -3.603 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
5,666%
11.53
|
0.20 | 10.70 | 10.22 | 9.754 |
| Diluted Average Shares |
5,666%
11.53
|
0.20 | 10.70 | 10.22 | 9.754 |
| Basic Earnings Per Share |
0.00%
-0.06
|
-0.06 | -0.32 | -0.24 | -0.37 |
| Diluted Earnings Per Share |
0.00%
-0.06
|
-0.06 | -0.32 | -0.24 | -0.37 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.88%
0.42%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Kapitalisierung:
|
Volumen (24h):